Ralph Schiess
Director Ejecutivo en ONCONETIX, INC. .
Fortuna: 55 568 $ al 31/05/2024
Cargos activos de Ralph Schiess
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ONCONETIX, INC. | Director Ejecutivo | 12/01/2024 | - |
| Director Técnico/Científico/I+D | 15/12/2023 | - | |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Director Ejecutivo | 01/01/2010 | - |
| Fundador | 01/01/2010 | - | |
| Director/Miembro de la Junta | 01/01/2010 | 01/01/2020 | |
| Director Técnico/Científico/I+D | 01/01/2020 | 01/05/2023 |
Historial de carrera de Ralph Schiess
Formación de Ralph Schiess.
| University of Zurich | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Estadísticas
Internacional
| Suiza | 3 |
| Alemania | 2 |
| Estados Unidos | 2 |
Operativa
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Ralph Schiess
- Experiencia
